Pathology Flashcards

(122 cards)

1
Q

Inflammatory response - vascular

A

Transient vasoconstriction
-> Vasodilatation
- arterioles first, induced by histamine and NO, so ↑ blood flow and ↑ hydrostatic pressure
-> ↑ vascular permeability
- phase 1 - immediate transient response, mediated by histamine, leukotrienes, neuropeptide susbtance P, bradykinin, short lived (<30mins) and reversible
- phase 2 - prolonged response after direct endothelial injury affecting all levels of microcirculation
-> Exudation
- inflammatory extravascular fluid with high protein concentration and specific gravity >1.02
- ↓ intravascular osmotic pressure and ↑interstital osmotic pressure, oedema
-> increased blood viscosity
-> blood stasis
-> margination of leucocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inflammatory response - cellular

A

Leukocyte extravasation
- margination
-> leukocyte adhesion to endothelium (regulated by endothelial binding receptors eg selectins, immunoglobulins, integrins, mucin-like glycoproteins)
-> leukocyte diapedesis (process of transmigration across endothelium, mainly in venules)
-> chemotaxis (elicited by exogeneous agents eg bacteria, and endogenous agents eg components of complement systems, leukotriene, cytokines)

Phagocytosis
- micobicidal substnaces released into extracellular space and phagolysosomes during phagocytosis by leukocytes
- eg lysosymal enxymes, reactive oxygen intermediates (H2O2), products of arachidonic acid metabolism (leukotrienes and prostaglandins)
- can cause endothelial and tissue damage including acute respiratory distress syndrome, acute transplant rejection, asthma, reperfusion injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chemical mediators of inflammation

A

MAIN ACUTE PHASE RESPONSE INDUCED BY TNF AND IL1

Haemogen factor activation - aka factor 12, from liver and plasma, works to activate kinin, clotting, fibrinolytic and complement systems
Complement system - from liver and plasma
Cytokines and NO - from endothelium and macrophages
Platelet activating factor - from endothelium and leukocytes
Serotonin - from platelets and mast cells, to increase vascular permeability
Histamine - from platelets and mast cells, assoc with IgE
Bradykinin - to increase vascular permeability, vasodilation, smooth muscle contraction, chemotaxis, activates Hageman factor. Formed by kallikrein, inactivated by ACE in lungs (protected by ACEi)
+ Prostaglandins, leukotrienes, platelet-activating factor, lysosomal enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Signs of inflammation

A

Raised ESR (due to RBC clumping)
Leucocytosis - increased no of immature neutrophils
4 cardinal signs - rubour (red), calor (heat), dolor (pain), tumour (swelling)
Virchow sign = loss of function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute inflammation

A

Rapid onset and short duration
VASCULAR/CELLULAR CHANGES
- initial vasoconstriction then vasodilation, slowing of circulation (stasis), margination of leukocytes, central sludging of RBCs
- increased vascular permeability
- exudation of fluid - serous, fibrinous, purulent
- emigration of leukocytes (mostly neutrophils)

-> complete resolution / fibrosis / abscess / chronic inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chronic inflammation

A

From persistent infection, prolonged exposure to foreign agents, or autoimmune
Can start de novo without acute inflammation
Characterised by - infiltration by macrophages, tissue destruction, attempted repair by proliferation of new blood vessels, and fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Granulomatous inflammation

A

Pattern of chronic inflammation characterised by granulomas (focal) and epitheloid cells (activated macrophages) surrounded by mononuclear leukocytes
All can contain giant cells

TB - caseating granuloma, Langhans giant cell, mantoux test
Cat-scratch disease - stellate granuloma, contains neutrophils
Sarcoidosis - non-caseating granuloma, Schaumann’s body, raised ACE levels, Kveim’s test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cellular adaptation

A

= cellular changes occuring in response to persistent physiological or pathological stress

ATROPHY - ↓cell size
- due to ↓ workload, loss of innervation/blood supply, inadequate nutrition, loss of endocrine stimulation, pressure

HYPERTROPHY - ↑cell size

HYPERPLASIA - ↑number of cells
- from increased cell mitosis, physiological (hormonal or compensatory) or pathological eg endometriosis

METAPLASIA - cell type replaced by another cell type, reversible but if stimuli persist then can -> cancer

DYSPLASIA - abnormal changes in cell shape and size, aka atypical hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cell injury

A

When limits of adaptive responses exceeded
Reversible or irreversible

See - ↓oxidative phosphorylation, ↓ATP, cellular swelling (aka hydropic degeneration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cell death

A

From irreversible cell injury
Necrosis = traumatic cell death
Apoptosis = programmed cell death
Autolysis = non-traumatic cell death occurring via action of own enzymes

See - mitochondrial damage, loss of membrane permeability
- pyknosis (condensation of chromatin), karyorrhexis (fragmentation of nuclear material), karyolysis (dissolution of nucleus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mechanisms of cell injury

A
  1. Depletion of ATP
    → anaerobic glycolysis → ↓pH and clumping of nuclear chromatin
    → ↓ protein synthesis → lipid deposition
    → failure of Na/K pump → influx of Ca and Na, loss of K, ER swelling, cellular swelling, loss of microvilli, bleb formation
  2. Influx of Ca → increased cytosol Ca, activation of endonuclease → DNA damage, ATPase → decreased ATP, phospholipase → decreased phospholipids →membrane damage, protease → disruption of cell membrane)
  3. Oxygen-derived free radicals → DNA lesions, protein fragmentation, membrane lipid peroxidation
    - can be neutralised by antioxidants (vitA/C/E, glutathione, superoxidase dismutase, iron+copper transport proteins)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Apoptosis

A

Programmed cell death
See - intact cell membrane, degradation of nuclear DNA. Cell shrinkage, chromatin condensation, formation of cytoplasmic blebs and apoptotic bodies, phagocytosis,
No proinflammatory markers
Extrinsic - via TNF receptor or Fas
Intrinsic (mitochondrial) - via release of pro-apoptotic molecules into cytoplasm via loss of Bcl-2 anti-apoptotic gene

PHYSIOLOGICAL
- during embryogenesis
- hormone-dependent involution
- elimination of harmful self-reactive lymphocytes
- induced by cytotoxic T-cells

PATHOLOGICAL
- in tumours
- atrophy after obstruction
- cytotoxic drugs and radiation
- cell injury in viral disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

B-cell lymphoma 2 gene

A

Family of oncogenes
Can be anti-apoptotic or pro-apoptotic
Live in mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Necrosis

A

Cell death in living tissues by enzymatic degradation
See - loss of membrane integrity, enzymatic digestion of cells, host reaction
Within 4-12h of insult
Gangrene is black necrotic tissue - wet (colliquative necrosis), dry (coagulative necrosis), gas (exotocin-producing clostridial species (usually C perfringens))
Patterns of necrosis determined by blood supply to organs
eg necrosis of striated tissue is rhabdomyolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Types of necrosis

A

COLLIQUATIVE = liquefaction
- due to action of tissue digestive enzymes
- mainly in CNS, kidney, pancreas
- caused by focal bacterial/fungal infections

COAGULATIVE
- hypoxic cell injury
- due to protein denaturation
- intracellular organelles disrupted, but shape of tissues maintained as proteins stick together

CASEOUS
- features between the two above
- tissues semi-solid/liquid

FIBRINOID
- due to immune-mediated vascular injury causing fibrin-like protein deposits in arterial walls

FAT
- due to lipase, tissues become chalky
- seen in breast, pancreas, omentum, skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What mediates cell injury

A

Lipids
- TAG causing steatosis eg heart, liver, kidney
- cholesterol causing atherosclerosis, xanthoma, foamy macrophages
Proteins
Hyaline changes
Glycogen
Pigments
- lipofuscin (end product of free radical injury, brown), melanin (from tyrosine), haemosiderin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cellular ageing process

A

Replicative senescence = cells have limited capacity for replication. After fixed no of divisions all cells arrest in terminally non-dividing state, caused by telomere shortening
Also influenced by free radical oxidate damage and genetic influence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Telomerase

A

Specialised enzyme made of RNA and protein, uses RNA as template for adding nucleotides to end of chromosomes
- maintains length of telomere
- prevents replicative sequence
- activity HIGH in germ cells, LOW in stem cells, absent in somatic cells, reactivated in cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Physiological response to injury

A

Immobility/rest
Loss of appetite
Catabolism

Minor - increased HR/RR/temp/WBC
Major - SIRS/hypermetabolism/catabolism/multiorgan dysfunction

Immunological and neuroendocrine responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Ebb and flow phases in response to injury

A

Ebb = shock
- begins immediately from injury, lasts 24-48hrs
- hypovolaemia, reduced CO, decreased basal metabolic rate, hypothermia, lactic acidosis
- catecholamines, cortisol, aldosterone are main hormones
- functions to conserve circulating volume and energy stores

Flow
- hypermetabolic, like SIRS
- initial catabolic phase 3-4 days to mobilise energy stores (weight loss, urinary nitrogen excretion), later anabolic phase lasting weeks
- tissue oedema, vasodilating, increased CO, hypermetabolism, increased temp, leukocytosis, increased oxygen consumption, increased gluconeogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Immunological response in injury

A

From proinflammatory to compensatory anti-inflammatory response CARS

Proinflammatory - mediated by innate immune system (interacts with adaptive immune system T and B cells) for pro-inflammatory cytokines (IL1, TNF, IL6, IL8) in first 24hrs, pyrexia due to action on hypothalamus, proteolysis in skeletal muscles, acute phase protein production in liver
- response followed by increased cytokine antagonists leading to CARS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Neuroendocrine response to injury

A

Biphasic:

ACUTE
- active secretion of pituitary and counter-regulatory hormones glucagon, cortisol, adrenaline

CHRONIC
- hypothalamic suppression and low serum levels of target hormone organs, so wasting

eg increased CRH from hypothalamus, increased secretion of ACTH from anterior pituitary, release of cortisol from adrenals
Counter-regulatory hormones to reduce insulin, increase metabolism, hepatic gluconeogenesis, adipocyte lipolysis, skeletal muscle protein catabolism, inactivate peripheral thyroid hormone, reduce testosterone, increase prolactin and GH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Energy expenditure in trauma

A

Increased by 25%
- central thermo-dysregulation
- increased sympathetic activity
- abnormalities in wound circulation - ischaemic areas produce lactate -> metabolised in Cori’s cycle, hyperaemic areas cause increased CO
- increased protein turnover

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Protein metabolism in response to injury

A

SKELETAL MUSCLE
Protein degradation in peripheral tissues (skin, skeletal muscle, adipose tissue)
Muscle catabolism cannot be inhibited fully, so turnover rate 1-2%/day

HEPATIC
Liver protein turnover rate 20%/day - 1/2 for renewal of structural protein and 1/2 for synthesis of export protein
- during inflammation hepatic synthesis of acute phase proteins (fibrinogen, CRP), and serum albumin decreased due to transcapillary escape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Wound healing
INFLAMMATORY - immediate until 2-3days - local vasoconstriction - thrombus formation and fibrin mesh - platelets line damaged endothelium, release ADP/platelet derived growth factor/cytokines/histamine/serotonin/prostaglandins - ADP causes thrombus aggregation - cytokines attract lymphocytes and macrophages - histamine causes increased capillary permeability PROLIFERATIVE - day 3-week 3 - fibroblast activity, producing collagen type 3 and ground substance using vitC - angiogenesis, re-epithelialisation of wound surface, formulation of granulation tissue REMODELLING - maturation of collagen from type 3 to type 1 - decrease wound vascularity and wound contraction
26
Wound closure
Primary intention - NOT acute inflammatory reaction - fibin-rich haematoma, then neutrophils at margin of wound within 24hrs and move towards clot - epithelial cells move from wound edge and deposite basement membrane in 24-48hr - macrophages replace neutrophils at day3 - granulation tissue invasion - neovascularisation maximal at day5 - fibroblast proliferation at week 2 - scar devoid of inflammatory cells by week4 Secondary intention - where wound edges not opposed, heals from bottom upwards - by granulation, contraction, epithelialisation - requires myofibroblasts
27
Wound healing factors
At week 1, skin is 10% strength vs un-wounded, at 3months is 80% Growth factors involved - EGF, TGF, VEGF, PDGF, FGF, IGF Promoted by good blood supply, vitamin C, zinc, protein, insulin, UV light Inhibited by glucocorticoids, infection, extreme temperatures
28
Scars
Matures over 2 years - immature is pink, hard, raised, itchy Mature - atrophic / hypertrophic (excess scar tissue not extending beyond boundaries of original wound, due to granulation tissue) / keloid (excess scar tissue beyond boundaries, due to persistant type 3 collagen) Treatment of keloid/hypertrophic: - excision of scar, laser, steroid injection, pressure, silicon gel sheeting, radiation, vitaminE Reduce surgical scarring: monofilament sutures, removal of sutures at day3-5, tensionless suturing, fine sutures and steri-strips, subcuticular technique
29
Neoplasia
= abnormal, uncontrolled, uncoordinated growth, which persists after cessation of stimuli Malignant neoplasia = invasion, rapid growth, metastases, poor differentiation
30
Tumour definitions
Carcinoma - epithelial origin Sarcoma - mesenchymal origin Teratoma - neoplasm with multiple germ cell layers (ovarian is benign, testicular is malignant) Choristoma - non-malignant mass of normal tissue in ectopic location Hamartoma - non-malignant mass of disorganised but mature tissue indigenous to site
31
Growth of tumour
Gompertzian - in early stages exponential growth, but slows as grows Majority of growth occurs before clinically detectable Radiologically needs to have - 10mm size, 10^9 cells 2^n = number of cells produced after n generations of division 2^45 is usually fatal (after 45 generations), but there is also concurrent tumour loss
32
Features of malignant transformation
* Establishment of autonomous lineage - resisting signals that inhibit growth, acquisition of independence from signal-stimulating growth, using oncogenes * Obtaining immortality - normal cells have finite no of divisions (40-60) determined by progressive shortening of telomere, but ca cells do not undergo telomeric shortening * Evasion of apoptosis (p53) * Angiogenic competence * Ability to invade * Ability to disseminate and implant * Evading detection and elimination * Genomic instability
33
Differentiation
Extent to which neoplastic cells resemble normal cells Benign = well differentiated (morphologically and functionally similar to mature normal cells) Anaplasia = lack of differentiation High-grade tumour = poorly differentiaed
34
Metastasis
ONLY cancers that can't are BCCs and gliomas LYMPHATIC - most carcinomas, eg endometrial, cervical BLOOD - most sarcomas, renal cell ca, choriocarcinoma BODY CAVITY - ovarian ca, breast ca, pseudomyxoma peritonei
35
Inherited genetic predisposition to cancer
Inherited syndromes (all autosomal dominant) - retinoblastoma, MEN, neurofibromatosis 1+2, von Hippel-Lau syndrome Inherited autosomal recessive syndromes of defective DNA repair - xeroderma pigmentosum, Fanconi's anaemia Familial cancers - breast, ovarian, HNPCC
36
BRCA genes
BRCA-1 - on long arm of chrom 17 - 80% lifetime risk breast ca, 50% ovarian ca BRCA-2 - on long arm of chrom 13 - 45% breast ca, 25% ovarian ca - also predisposes to prostate and pancreatic ca Other cancer genes - HNPCC, RB (retinoblastoma), p16 (melanoma)
37
HNPCC
Hereditary non-polyposis colonic cancer, aka Lynch syndrome Autosomal dominant inheritance 5 genes 80% lifetime risk colonic ca, 30-50% endometrial ca, 10% ovarian ca
38
Non-genetic predisposing factors to cancer
Chronic inflammation - crohn's, UC Pre-cancerous conditions - leukoplakia, cervical dysplasia, pernicious anaemia Carcinogenic agents - asbestos - mesothelioma, GI tract ca - diethylstilbestrol (synthetic oestrogen) - vaginal clear cell ca - high fat/low fibre - colonic ca - aniline dye - bladder ca - HPV 16/18 - cervical ca - anabolic steroids or HepB - hepatocellular ca
39
Tumour markers
hCG - trophoblastic (choriocarcinoma), non-seminomatous germ cell tumour Calcitonin - medullary ca of thyroid Catecholamines - phaeochromocytoma AFP - hepatocellular ca, non-seminomatous germ cell tumour CEA (carcinoembryonic antigen) - colonic, pancreatic, gastric, lung PSA - prostate Immunoglobulins - multiple myeloma Ca125 - ovarian ca, primary peritoneal ca Ca19-9 - colonic, pancreatic Ca15-3 - breast
40
Paraneoplastic syndromes
Symptom complexes in ca patients - not due to spread of ca but due to endocrine function or immunological response Cushing's - small cell lung, pancreatic SIADH - small cell lung, intracranial Carcinoid syndrome - bronchial adenoma, pancreatic, gastric Polycythaemia - renal cell, cerebellar haemangioma, hepatocellular ca, fibroid Myasthenia - bronchogenic ca Acanthosis nigrans - lung, uterine ca Dermatomyositis - bronchogenic, breast Trousseau's - pancreatic
41
p53
Transcription factor that regulates cell cycle - activates DNA repair, initiates apoptosis Tumour suppressor On chrom17 Li-Fraumeni syndrome - AD disorder linked to p53 mutation, 25x greater chance of malignancy by age 50
42
Anti-thrombotic agents
Anti-platelet - prostacyclin - NO - ADPase Anti-coagulant - thrombomodulin - anti-thrombin III - tissue factor pathway inhibitor Fibrinolytic - tissue-type plasminogen activator (t-PA)
43
Pro-thrombotic agents
Pro-platelet - von Willebrand factor Pro-coagulant - thromboplastin Anti-fibrinolytic - plasminogen activator inhibitor
44
Platelets -> haemostatic plug
Platelets contain fibrinogen, fibronectin, PDGF, histamine, serotonin, factor V and VIII Platelet aggregation induced by vWF, ADP, thromboxane A2 PRIMARY HAEMOSTATIC PLUG - platelet aggregation, reversible SECONDARY HAEMOSTATIC PLUG - thrombin binds to platelets, irreversible FIBRIN BINDS TO PLUG - ADP mediated activation of platelets, causes changes to their surface receptor for fibrinogen, so fibrin can form and bind to the plug
45
Coagulation cascade
INTRINSIC: - from contact activation (surface damage) - using factors XII XI IX VIII (12, 11, 9, 8) - both activate factor X (test using PTT - play table tennis inside, 25-29s) EXTRINSIC: - from tissue factor (III) released in trauma and inflammation - using factors III (TF), VII (3 +7 = 10) - both activate factor X (test using PT - play tennis outside, 12s) COMMON: - activated factor X, causes prothrombin -> thrombin (II) (Ca and factor V (co-factor) are needed here) - which then cleaves fibrinogen -> fibrin (I) (factors 2, 7, 9, 10 are vitamin K dependent)
46
Proteins C and S
Protein C - physiological anticoagulant - degrades factor Va and VIIIa - activated by thrombin Protein S - anticoagulant - cofactor with activated protein C for the degradation of factor Va and VIIIa - binds to complement factors
47
Factor V Leiden
Variant of factor V that cannot be inactivated by protein C -> hypercoagulant state Autosomal dominant 5% prevalence in caucasians 30% of patients with DVT or PE have
48
Fibrinolytic cascade
By generation of plasmin Plasminogen -> plasmin via Hageman dependent pathway, plasminogen activators (tissue-type PA and urokinase-like PA)
49
Changes to coagulation in pregnancy
Physiological ↓ in platelet levels - due to haemodilution Hypercoagulant - ↑levels of coagulant factors ↑ fibrinogen ↑ ESR Fibrinolytic system - placenta secretes PAI-2 which inhibits fibrinolytic system, ↑ anti-thrombin III, ↑ FDPs - activity remains low in labour but returns to normal 1hr after delivery of placenta
50
Virchow's triad
Endothelial injury Stasis Hypercoagulability
51
Hypercoagulability states
PRIMARY (genetic) disorders - protein C or S deficiency - anti-thrombin III deficiency - factor V Leiden SECONDARY (acquired) - pregnancy - COCP - antiphospholipid antibodies - nephrotic syndrome - Trousseau's syndrome - heparin induced thrombocytopenia syndrome
52
Thrombosis
Venous, arterial or cardiac Based on Virchow's triad - endothelial injury, stasis, hypercoagulability Fate - propagation / embolisation / dissolution / organisation and recanalization
53
Antiphospholipid syndrome
= Hughes' syndrome Triad for definition - thrombosis (arterial or venous), recurrent miscarriage (>3 consecutive at <10 weeks), antiphospholipid antibodies Autoimmune Also see PET, preterm deliveries, thrombocytopenia, livedo reticularis Primary if no other autoimmune conditions, secondary if also eg SLE Fetal loss due to pro-coagulant state, and decreased level of annexin-V (anticoagulant on normal placental villi) Treat - aspirin, and anticoagulants LMWH
54
Antiphospholipid antibodies
Heterogenous antibodies directed against anionic phospholipids or their binding proteins (prothrombin, factor V, protein C and S, annexin V) Lupus anticoagulant and anticardiolipin antibodies 2-5% of normal obstetric population, 15% of those with recurrent miscarriage, 30% if SLE
55
Heparin-induced thrombocytopenia syndrome
Formation of antibodies that bind to heparin-platelet complex So activates platelets -> low platelet count, thrombosis Treat with lepirudin (thrombin inhibitor)
56
Disseminated intravascular coagulation
= consumptive coagulopathy Causes - cancer, massive tissue injury, massive haemorrhage, infection, liver disease, placental abruption, pre-eclampsia, amniotic fluid embolism Features - ↑PT, ↑APTT, high levels FDPs, ↑ soluble fibrin complex, ↓ fibrinogen, high D-dimer, thrombocytopenia, fragmented RBCs (schistocytes) on blood film
57
Embolism
eg pulmonary thromboembolism - 60% silent, -> cor pulmonale (RV failure) Fat embolism - neurological symptoms, pulmonary insufficiency, anaemia, thrombocytopenia Air embolism - eg decompression sickness Amniotic fluid embolism - 1 in 8000 - 80,000 deliveries - 60% mortality rate
58
Thrombocytopenia
5-10% term pregnancies Gestational TP - benign, no treatment, will return to normal post delivery TTP = thrombotic thrombocytopenic purpura - thrombocytopenia with microangiopathic haemolytic anaemia and renal impairment - platelet consumption disorder - treatment is plasma exchange (NOT platelet transfusion) If PLT >80 - regional anaesthesia safe if >50 - LMWH is safe
59
Causes of thrombocytopenia
Immune thrombocytopenic purpura Haemolytic uraemic syndrome Thrombotic thrombocytopenic purpura Bone marrow suppression Gestational thrombocytopenia HELLP syndrome SLE and antiphospholipid syndrome DIC HIV
60
ITP
Due to antibodies against platelet surface glycoproteins 1-2:10,000 pregnancies Antiplatelet IgG - can cross placenta and cause fetal thrombocytopenia Treatment - corticosteroids, immunoglobulins, splenectomy, azathioprine, platelet transfusion
61
Infarction
Area of ischaemic necrosis caused by occlusion of either arterial supply or venous drainage to tissue Causes - thrombosis, embolism, vasospasm, expansion of atheroma, extrinsic compression of vessel Red (haemorrhagic) - due to venous obstruction White (anaemic) - due to arterial obstruction
62
Septic ladder
SIRS = 2 of: - temp <36 or >38 - tachycardia >90 - tachypnoea >20 - WBC <4 or >12 Sepsis is SIRS if result of infection Severe sepsis is if also evidence of failure of >1 organ system MODS = 2 or more failed organ systems, 60% mortality
63
Abscess
= collection of pus (dead and dying WBCs) surrounded by acute inflammatory response and pyogenic membrane Contains hyperosmolar material that draws fluid in and increases pressure, causing pain If related to surgical wound, usually takes 7-10 days to form Outcome - resolution by I+D, antibiotics, chronic abscess (with plasma cells and lymphocytes), fistula, sinus
64
Determinants of wound infection
Host response Virulence and inoculums of infective agent Vascularity and tissue health Presence of foreign body Presence of antibiotics during decisive period
65
Categories of surgery according to infection risk
Clean (if +abx prophylaxis infection rate is 2%) Clean-contaminated (" 10%) Contaminated (" 20%) Dirty (" 40%)
66
Shock
Systemic state of low tissue perfusion, inadequate for normal cellular respiration Pathogenesis: - lack of O2 -> anaerobic respiration -> lactic acid -> metabolic acidosis - consumption of cellular glucose stores -> cessation of anaerobic respiration -> cell lysis -> hyperkalaemia - hypoxia and acidosis activate immune and coagulation systems -> increased capillary permeability Cardio - decreased preload and afterload cause reflex tachycardia and vasoconstriction, reduced perfusion -> hypothermia Resp - metabolic acidosis so increased RR and minute ventilation (to excrete CO2), -> compensatory respiratory alkalosis Renal - reduced glomerular filtration, oliguria, activation of renin-angiotensin system, vasoconstriction Hormonal - ADH and cortisol release
67
Ischaemia-reperfusion injury
Metabolites (H and K) that build up during tissue hypoperfusion are flushed back into systemic circulation -> acute lung injury -> acute renal injury -> MODS
68
Causes of shock
HYPOVOLAEMIC - haemorrhoagic, non-haemorrhagic, 3rd spacing CARDIOGENIC - MI, arrhythmia without output OBSTRUCTIVE - tamponade, PE, pneumothorax DISTRIBUTIVE - septic, anaphylactic, neurogenic ENDOCRINE - adrenal insufficicency, hypo/hyperthyroidism
69
Occult hypoperfusion
When normal vital signs but continued tissue hypoperfusion Due to low mixed venous oxygen saturation, persistent lactic acidosis Or global hypoperfusion - see base deficit, lactate
70
Dynamic fluid response
Based on response to 250-500ml IV fluid challenge: RESPONDER - sustained improvement, no active bleeding or fluid loss TRANSIENT RESPONDER - improve but then revert back to previous state over 20 mins (have ongoing fluid loss) NON-RESPONDER - show no improvement
71
Central venous pressure
Normal CVP = 5-15cm H2O After IV fluid challenge - should get CVP rise of 2-5, then drifting back over 20 mins - if no response then underfilled - large sustained response then overfilled
72
Mixed venous oxygen saturation
From RA Measure of O2 delivery and extraction by tissues Normal value 50-70% If <50% - inadequate oxygen delivery, or increased oxygen extraction If >70% - in sepsis due to decreased utilisation of O2 at cellular level
73
Haemorrhage
Leads to acidosis, hypothermia, coagulopathy Degree of haemorrhage - <15% is within limits of compensatory mechanism (at expense of GI tract, muscle, skin) 15-30% decompensation starts 30-40% BP falls >40% severe
74
Types of haemorrhage (primary/reactionary/secondary)
Primary - immediate Reactionary - delayed but within 24hr of event, can be due to dislodgement of clot/vasodilation/normalisation of BP Secondary - within 7-14 days of primary event, caused by sloughing of vessel wall
75
Blood transfusion
Packed red cells - 330ml RBC, 250mg iron, stored at 2-6 degrees, 5 week shelf life Fresh frozen plasma - stored at -40degrees, shelf life 2 years Cryoprecipitate - rich in factor VIII and fibrinogen Platelets - stored at 20-24degrees, shelf like 5 days
76
Complications of transfusion
Single transfusion - haemolytic (ABO incompatibility) - febrile (graft vs host response from residual leukocytes in blood) - allergic - infection - air embolism - thrombophlebitis - transfusion-related acute lung injury (from FFP) Massive transfusion - coagulopathy - hypocalcaemia, hyper/hypokalaemia, hypothermia, iron overload
77
Management of transfusion induced coagulopathy
FFP if PT>1.5x normal Cryoprecipitate if fibrinogen <0.8 Platelets if <50 TXA Aprotinin Recombinant factor VIIa
78
Cervical screening
Every 3 years in 25-49yo Every 5 years in 50-65yo False negative 10% Borderline/mild dyskariosis 10% Moderate/severe dyskariosis 2% Inadequate 10%
79
Cervical intraepithelial neoplasia
Form of cervical dysplasia, premalignant Major aetiology HPV 16 and 18 Most spontaneously regress, or progression to cancer takes 15years Cytology - nuclear enlargement, increased nuclear:cytoplasmic ratio, nuclear pleomorphism, hypochromasia, increased mitotic activity
80
Cervical glandular intraepithelial neoplasia
Usually coexists with squamous disease Multifocal in 15%
81
Cervical cancer
9:100,000, commonest gynae ca worldwide Mean age presentation is 52yo, but bimodal distribution with peaks in late 30s and early 60s 99.7% of cervical ca due to all types of HPV (70% due to 16 and 18) Squamous cell 80% Adenocarcinoma 15% <1% small cell ca (neuroendocrine, poor pronosis as early spread), clear cell ca, glassy cell ca
82
Classification of cervical cancers
Stage 0 - ca in situ Stage 1 - 1A - limited to cervix, micro-invasive - treat with LLETZ/trachelectomy/hysterectomy - 1B - visible lesion - need radical hysterectomy and lymphadenectomy Stage 2 - invades beyond uterus but not to pelvic floor or lower 1/3 vagina - 2A without parametrial - 2B with parametrial - treat with radiation, cisplatin-based chemotherapy, and hysterectomy Stage 3 - extends to pelvic side wall or lower 1/3 vagina or hydronephrosis - 3A - no side wall - 3B - side wall or hydronephrosis - treat with radiation therapy and cisplatin-based chemo Stage 4 - extends beyond true pelvis - 4A - bladder and rectum - 4B - distant mets - radiation + chemo
83
Uterine fibroids
= leiomyomas Oestrogen dependent benign tumours Arise from uterine smooth muscle No evidence that can become malignant, risk to leiomyosarcoma 0.25% Microscopically, tumor cells resemble normal cells (elongated, spindle-shaped, with a cigar-shaped nucleus) and form bundles with different directions (whorled). These cells are uniform in size and shape, with scarce mitoses. Degeneration due to outgrowing blood supply - hyaline most common, or red in pregnancy Intravenous leiomyomatosis is variant fibroid - can metastasize via haematological spread, in any organ
84
Endometriosis
Ectopic endometrium (stroma + glands) Frequently in POD and ovaries In women of fertile age, 1-2% Unknown aetiology - theories oestrogen dependent, genetic, transplantation, retrograde implantation from menstruation Can be associated with cancers eg clear cell carcinoma Dysmenorrhoea, dyspareunia, dyschezia, dysuria, chronic pelvic pain, infertility in 40% Ca125 elevated Histologically see haemosiderin-laden macrophages
85
Staging of endometriosis
1 - superficial lesions and filmy adhesions 2 - deep lesions at cul-de-sac 3 - all above + endometriomas on ovaries 4 - all above + extensive adhesions
86
Adenomyosis
Presence of endometrial glands in myometrium 20%
87
Endometrial hyperplasia
Related to prolonged oestrogen stimulation of endometrium Simple, complex or atypical (atypical highest rate of progression to malignancy endometrial adenocarcinoma, 25-50%) Treatment - progestogens for simple/complex - TAH + BSO for atypical
88
Endometrial cancer risk factors
Endometrial hyperplasia Hypertension Ovarian ca, breast ca Diabetes Tamoxifen, oestrogen Late menopause Early menarche Obesity Nulliparity
89
Endometrial cancer types
Carcinoma - non-endometroid (papillary serous or clear cell, both poorly differentiated with poorer prognosis) - or endometroid Sarcoma From pluripotent stem cells in endometrium HOMOLOGOUS if contain endometrial tissue only - stromal or glandular, HETEROLOGOUS if they contain extra-uterine tissue such as skeletal muscle or cartilage, PURE if differentiation occurs along one cellular pathway only - for instance, an endometrial stromal sarcoma, MIXED if differentiation occurs along more than one cellular pathway - for instance containing both endometrial stromal sarcoma and endometrial adenocarcinoma Poor prognosis
90
Staging of endometrial cancer
1 - limited to uterus, 85-90% 5 year survival 1A - invasion <1/2 myometrium 1B - invasion >1/2 myometrium 2 - cervical stromal invasion, 65% 5yr survival 3 - extension beyond uterus but confined to pelvis, 45-60% 5yr survival 3A - invasion of serosa, adnexa, peritoneal fluid 3B - vaginal invasion 3C - nodal involvement 4 - distant mets, 15% 5yr survival 4A - mucosa of rectum and bladder 4B - distant mets including abdominal and/or inguinal lymph
91
PCOS
5% prevalence Based on Rotterdam criteria, need 2/3 of: - oligo-ovulation - excess androgen activity - polycystic ovaries on imaging (>12 follicles in each ovary measuring 2-9mm in diameter, or ovarian volume >10ml) High androgen activity due to - high LH, decreased SHBG, increased insulin, extra-ovarian production of androgens (eg Cushing's, CAH) High LH:FSH ratio 2:1 or more Higher risk of endometrial hyperplasia/neoplasia, insulin, resistance, dyslipidaemia
92
Primary ovarian cancers
EPITHELIAL 85% - serous (75%), mucinous, Brenner's (transitional cells, secrete oestrogen, mostly benign, can be bilateral), clear cell, differentiated, endometroid (assoc with endometriosis), fibroma STROMAL 5% - sertoli-leydig (testosterone secreting, usually benign), thecofibroma, granulosa (oestrogen secreting, see Kall-Exner bodies) GERM CELL 5% (or 70% in under 20s) - germinoma, endodermal sinus tumour (secretes AFP and a-antitrypsin), choriocarcinoma (secretes hCG), teratoma, embryonal (secretes LDH)
93
Secondary ovarian cancers
From peritoneal, endometrium, breast, and GI tract cancers Krukenberg cancer = secondary ovarian from GI primary, characterised by mucin-secreting signet-ring cells, usually affects both ovaries
94
Teratomas
Includes dermoid cysts (from all 3 germ cell layers), mature teratomas, struma ovarii (mostly thyroid tissue, can cause hyperthyroidism), carcinoid component Benign teratoma is the commonest ovarian tumour (40%) - bilateral in 10-15% - 1% undergo malignant transformation
95
5 year survival rate for all stages of ovarian cancer
45%
96
Ovarian cancer tumour markers
Biochemical: - ca125 (elevated in 50% with early disease, 80% with late) - ca119 or CEA in mucinous - AFP in germ cell - B-HCG in choriocarcinoma - LDH in dysgerminoma Cytokeratins - CK 7 positive - CK 20 negative Risk of malignancy index (RMI) = CA125 x menopausal status x ultrasound features - premenopausal = 1, post = 3 - >1 USS feature seen = 3 - RMI>200 highly indicative of malignancy
97
Lichen sclerosus
aka chronic atrophic vulvitis Autoimmune All ages but common after menopause See - narrowed introitus, labial atrophy, epidermal atrophy, hydropic degeneration of basal layer, dermal inflammation, sclerotic stroma 5% have association with squamous vulval carcinoma
98
Staging of ovarian carcinoma
1 - limited to 1 or both ovaries 1A - 1 ovary, peritoneal washings -ve 1B - both ovaries, peritoneal washings -ve 1C - capsule ruptures, peritoneal washings +ve 2 - pelvic extensions 2A - implants on uterus 2B - implants on pelvic structure 2C - peritoneal washings +ve 3 - peritoneal implants beyond pelvis or with extension to small bowel/omentum 3A - microscopic implants 3B - macroscopic <2cm 3C - macroscopic >2cm 4 - distant metastasis
99
Lichen simplex chronicus
aka hyperdysplastic dystrophy Secondary to pruritus See - acanthosis of vulval squamous epithelium, hyperkeratosis, thickened epithelium, increased mitotic activity in basal and prickle cell layer
100
Vulval intraepithelial neoplasia
See - epithelial nuclear atypia, increased mitosis, lack of surface differentiation 90% associated with HPV 10-30% assoc with another primary squamous neoplasm in vagina or cervix
101
Extramammary Paget's
Non-invasive intraepithelial adenocarcinoma Not usually associated with underlying invasive malignancy Can be assoc with adenocarcinoma arising from urethra, rectum or Bartholin's gland Lesion - sharp demarcation, erythematous, pruritic
102
Vulval cancer
4% of gynae cancers, 3/100,000 women, median age 74yo Usually presents with itching Types - SCC 85%, melanoma 5%, BCC, adenocarcinoma, sarcoma
103
Vulval cancer staging
1 - confined to vulva 1A - lesions <2cm with stromal invasion <1mm 1B - lesions >2cm, stromal invasion >1mm 2 - extension to adjacent perineal structures, eg 1/3 lower vagina, 1/3 lower urethra, anus 3 - positive inguino-femoral nodes 3A - <2 lymph node mets 3B - >2 lymph node mets 3C - with extracapsular spread 4 - extension to upper urethra and vagina 4A - upper vagina, upper urethra, bladder, rectum 4B - distant mets including pelvic lymph nodes
104
Vaginal cancer
1% of gynae cancer Primary carcinoma uncommon Associated with HPV Types - 90% SCC, adenocarcinoma, germ cell, sarcoma Botryoides
105
Pre-eclampsia
BP >140/90 with proteinuria, after 20w gestation 2-3% of pregnancies (HTN in 10-15%) 2% of those with PET -> eclampsia Unknown aetiology Pathophysiology ?due to poor placentation -> utero-placental resistance and abnormal placental function - vasoconstricted - plasma contracted - intravascular coagulation - endothelial dysfunction (↑ capillary permeability, ↑ vascular tone, ↑ fibronectin, platelet thrombosis) - biochemical - ↓NO, ↓ thromboxane A2, angiotensin and endothelin, ↓prostacyclin
106
Classification and features of PET
Mild - BP >140/90 - proteinuria 300mg/24hr Severe - BP >160/110 - proteinuria >5g/24hr Features - headache, visual disturbance, epigastric/RUQ pain, vomiting, ankle swelling, seizures - hyper-reflexia, clonus, oliguria - deranged LFTs, low platelets, abnormal renal function, deranged clotting, elevated urinary protein
107
Risk factors for PET
Age >40 BMI >30 Family hx Primip Multiple pregnancy Previous hx Hydatidiform mole Pre-existing HTN Renal disease Diabetes Antiphospholipid syndrome
108
Complications of PET
Haemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome Placental abruption FGR Eclampsia Pulmonary oedema DIC Commonest causes of death in PET - cerebral haemorrhage, ARDS
109
Obstetric cholestasis
Features - pruritus of limbs and trunk (palms and soles especially), no rash, abnormal LFTs, rare to have jaundice Multifactorial poorly understood pathogenesis Complications - vitK deficiency, PPH, pre-term delivery, intrapartum fetal distress, intrauterine fetal death 1-4%, fetal intracranial haemorrhage Risk of recurrence 90% in future pregnancies
110
Acute fatty liver of pregnancy
Usually after 30w gestation RFs - primigravida, obesity, male fetus, multiple pregnancy 10-20% maternal mortality, 20-30% fetal mortality Features - vomiting, abdo pain, jaundice, abnormal LFTs, profound hypoglycaemia, hyperuricaemia, coagulopathy Complications - fulminant hepatic failure, encephalopathy
111
HELLP syndrome
Haemolysis, elevated liver enzymes, low platelets 20% of those with severe PET Pathogenesis - endothelial cell injury, microanngiopathic platelet activation and consumption Effects on pregnancy - abruption, acute renal failure, hepatic necrosis, liver rupture, subcapsular liver haematoma Perinatal mortality 10-60%, maternal 1% Risk of recurrence in future pregnancies low, but risk of PET high (75%)
112
Peripartum cardiomyopathy
Dilated cardiomyopathy From 8mo gestation to 5mo postpartum Assoc with congestive HF, ↓LVEF, cardiac arrhythmias, thromboembolism Cause unknown, diagnosis of exclusion Maternal mortality 25-50% Management - diuretics, B-blockers, ACEi, anticoagulation, or if refractory then LV assist device or heart transplant
113
Coombs' test
Positive if agglutination occurs Indirect - detects antibodies against RBCs present in patient's serum, used for antibody screening (cross-matching and antenatal screening) Direct - detects antibodies bound to RBC surface antigens, indicates immune-mediated attack o RBCs - alloimmune haemolysis (haem disease of newborn) - autoimmune haemolysis (SLE, idiopathic, secondary to lymphoproliferative disease or infection) - drug-induced immune-mediated haemolysis (methyldopa, penicillin, quinidine)
114
Kleihauer's test
To measure fetal RBCs in maternal circulation Normally fetal maternal haemorrhage is <4ml at delivery Anti-D immunoglobulin - 500IU neutralizes 4ml of RH+ve RBC - should be given within 72hr of sensitisation in non-sensitised Rh-ve women - provides protection for 6 weeks
115
Sheehan's syndrome
Hypopituitarism - caused by ischaemic necrosis due to blood loss and hypovolemic shock during and after childbirth Signs - absence or difficulty with lactation, amenorrhea / oligomenorrhea and features of hypothyroidism (tiredness, weight gain etc) due to reduced TSH.
116
Arias-Stella reaction
Due to direct effect of progesterone on the endometrium - endometrial epithelial cells become increasingly vacuolated and thrown into pseudo-papillary folds giving a hyper-secretory impression, evidence of decidualisation around spiral arteries and under the surface of the epithelium - glandular hyperplasia, intra-nuclear cytoplasmic invaginations which may resemble viral inclusions - in normal intra-uterine pregnancy, ectopic pregnancy, progestogen therapy and can also occur in the endocervix
117
Endometrial appearance with contraceptives
COCP - glandular atrophy Copper IUD - mononuclear cell infiltration, irregular polymorphs near the surface, foci of haemorrhage and squamous metaplasia may be present, cyclical changes persist Progesterone IUS - progestogenic effects including decidual change and inactive or weakly secretory glands with thinning of the endometrial lining
118
Endodermal sinus tumour
= yolk sac Rapidly growing Intraperitoneal spread Germ cell tumours Typically produce AFP Occur in young women See Schiller-duval bodies
119
Dysgerminoma
= the seminoma in males - commonest malignant germ cell tumour; occur in young women between the ages of 13 - 30 years - 10-15% are bilateral; solid tumours which typically present with abdominal mass or pressure symptoms - lymphatic spread to the para-aortic nodes - very radio-sensitive - no reliable serum marker but commonly see elevated LDH, occasionally hCG - karyotyping recommended
120
Ovarian choriocarcinoma
- usually a secondary from a uterine tumour - primary ovarian choriocarcinoma is rare and develops from germ cells - solid tumours, typically unilateral with cytotrophoblasts and syncytiotrophoblasts on histological examination - produce HCG
121
Meig's syndrome
Triad of benign ovarian tumour (typically thecoma/fibroma), ascites and pleural effusion Thecomas may produce oestrogen with a presentation similar to that described for granulosa tumours. Less likely to rupture Fibromas with > 3 mitoses per 10 high power fields are considered fibrosarcomas
122
Psammoma bodies
Concentric lamellated calcified structures, most commonly in papillary thyroid carcinoma (PTC), meningioma, and papillary serous cystadenocarcinoma of ovary Contain calcium